MID2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.639200E-01
Normal-vs-Stage2
5.145200E-01
Normal-vs-Stage3
1.825570E-01
Normal-vs-Stage4
7.931000E-01
Stage1-vs-Stage2
4.249600E-01
Stage1-vs-Stage3
1.311820E-01
Stage1-vs-Stage4
9.795800E-01
Stage2-vs-Stage3
1.829050E-01
Stage2-vs-Stage4
4.386200E-01
Stage3-vs-Stage4
2.183800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.063800E-01
Normal-vs-AfricanAmerican
9.903800E-01
Normal-vs-Asian
2.286800E-01
Caucasian-vs-AfricanAmerican
5.078200E-01
Caucasian-vs-Asian
2.065400E-01
AfricanAmerican-vs-Asian
1.790590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.279200E-01
Normal-vs-Female
5.436000E-01
Male-vs-Female
3.269000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.894000E-01
Normal-vs-Age(41-60Yrs)
9.993000E-01
Normal-vs-Age(61-80Yrs)
4.786200E-01
Normal-vs-Age(81-100Yrs)
2.537800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.654600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.236800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.340200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.682400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.60340000000226E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.240000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.823830E-01
Normal-vs-Daily Drinker
3.761400E-01
Normal-vs-Weekly Drinker
3.869000E-01
Normal-vs-Occasional Drinker
7.784000E-01
Normal-vs-Social Drinker
8.225600E-01
Non Drinker-vs-Daily Drinker
3.362200E-01
Non Drinker-vs-Weekly Drinker
4.888400E-01
Non Drinker-vs-Occasional Drinker
5.642100E-02
Non Drinker-vs-Social Drinker
5.514000E-02
Daily Drinker-vs-Weekly Drinker
3.471600E-01
Daily Drinker-vs-Occasional Drinker
3.658800E-01
Daily Drinker-vs-Social Drinker
3.893200E-01
Weekly Drinker-vs-Occasional Drinker
3.329400E-01
Weekly Drinker-vs-Social Drinker
1.496630E-01
Occasional Drinker-vs-Social Drinker
4.214800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.580600E-01
Normal-vs-Grade 2
8.264800E-01
Normal-vs-Grade 3
9.072200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.685200E-01
Grade 1-vs-Grade 3
4.872600E-01
Grade 1-vs-Grade 4
1.580600E-01
Grade 2-vs-Grade 3
3.236000E-01
Grade 2-vs-Grade 4
8.264800E-01
Grade 3-vs-Grade 4
9.072200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.148800E-01
Normal-vs-NonDiabetic
4.598400E-01
Diabetic-vs-NonDiabetic
2.821000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.596600E-01
Normal-vs-NoPancreatitis
5.026800E-01
Pancreatitis-vs-NoPancreatitis
3.790400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.477400E-01
Normal-vs-N1
4.806400E-01
N0-vs-N1
3.566400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.422200E-01
Normal-vs-TP53-NonMutant
3.564800E-01
TP53-Mutant-vs-TP53-NonMutant
2.584200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
